{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:11:52Z","timestamp":1791223912612,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772209"],"award-info":[{"award-number":["81772209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601804"],"award-info":[{"award-number":["81601804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Wuxi Science and Technology Bureau","award":["N20192021"],"award-info":[{"award-number":["N20192021"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS-2021-I2M-1-001"],"award-info":[{"award-number":["CIFMS-2021-I2M-1-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neurosyphilis may cause irreversible neurological sequelae. First-line treatment consists of penicillin G, with ceftriaxone being an alternative treatment in patients allergic to penicillin. The lack of clinical data comparing the efficacy of these two drugs indicated the need for comparative clinical trials to improve national treatment guidelines in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>In this multicenter randomized controlled clinical trial, 290 patients newly diagnosed with neurosyphilis will be randomized 1:1 to treatment with aqueous crystalline penicillin G (ACPG) or ceftriaxone. Patients will be treated with standard regimens of ACPG or ceftriaxone according to Chinese National Guidelines and will be followed up for 12 months. All clinical parameters will be assessed at baseline and at follow-up 3, 6, 9, and 12 months later. The primary outcomes will include cerebrospinal fluid (CSF) white blood cell (WBC) count, serological efficacy, and clinical efficacy. The secondary outcomes will include CSF protein concentrations, Mini-Mental State Examination (MMSE) scores, imaging results, recurrence, and time to recovery from neurosyphilis. Adverse events will be monitored and recorded during the trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial will provide clinical data to determine whether ceftriaxone is non inferior to ACPG in treating neurosyphilis and will provide evidence for the improvement of treatment guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry ChiCTR2100047164. Registered on 9 June 2021 and updated on 23 November 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06769-w","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T18:02:22Z","timestamp":1664647342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ceftriaxone compared with penicillin G for the treatment of neurosyphilis: study protocol for a multicenter randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Fang-Zhi","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Zhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-3826","authenticated-orcid":false,"given":"Qian-Qiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"6769_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/B978-0-7020-4088-7.00098-5","volume":"121","author":"JR Berger","year":"2014","unstructured":"Berger JR, Dean D. Neurosyphilis. Handb Clin Neurol. 2014;121:1461\u201372. https:\/\/doi.org\/10.1016\/B978-0-7020-4088-7.00098-5.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"6769_CR2","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","volume":"17","author":"M Unemo","year":"2017","unstructured":"Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235\u2013e79. https:\/\/doi.org\/10.1016\/S1473-3099(17)30310-9.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"6769_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.35541\/cjd.20210098","volume":"54","author":"XL Yue","year":"2021","unstructured":"Yue XL, Gong XD, Li J, et al. Trends and epidemiologic features of syphilis in China, 2014-2019. Chin J Dermatol. 2021;54(7):47\u201351. https:\/\/doi.org\/10.35541\/cjd.20210098.","journal-title":"Chin J Dermatol"},{"issue":"3","key":"6769_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/OLQ.0000000000000723","volume":"45","author":"S Tuddenham","year":"2018","unstructured":"Tuddenham S, Ghanem KG. Neurosyphilis: knowledge gaps and controversies. Sex Transm Dis. 2018;45(3):147\u201351. https:\/\/doi.org\/10.1097\/OLQ.0000000000000723.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"6769_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187. https:\/\/doi.org\/10.15585\/mmwr.rr7004a1.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"6769_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.35541\/cjd.20190808","volume":"53","author":"National Center for STD Control, China Centers for Disease Control and Prevention","year":"2020","unstructured":"National Center for STD Control, China Centers for Disease Control and Prevention. Guidelines for the diagnosis and treatment of syphilis, gonorrhea and chlamydia trachomatis infection (2020). Chin J Dermatol. 2020;53(3):168\u201379. https:\/\/doi.org\/10.35541\/cjd.20190808.","journal-title":"Chin J Dermatol"},{"issue":"2","key":"6769_CR7","first-page":"117","volume":"9","author":"R Gilad","year":"2007","unstructured":"Gilad R, Lampl Y, Blumstein G, et al. Neurosyphilis: the reemergence of an historical disease. Isr Med Assoc J. 2007;9(2):117\u20138.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"6769_CR8","doi-asserted-by":"publisher","first-page":"29Y35","DOI":"10.1159\/000079391","volume":"52","author":"C SendinMA","year":"2004","unstructured":"SendinMA C, Amela Peris R, BenitoY A, et al. Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol. 2004;52(1):29Y35. https:\/\/doi.org\/10.1159\/000079391.","journal-title":"Eur Neurol"},{"key":"6769_CR9","doi-asserted-by":"publisher","first-page":"45339","DOI":"10.1038\/srep45339","volume":"7","author":"W Tang","year":"2017","unstructured":"Tang W, Huang S, Chen L, et al. Late neurosyphilis and tertiary syphilis in Guangdong Province, China: results from a cross-sectional study. Sci Rep. 2017;7:45339. https:\/\/doi.org\/10.1038\/srep45339.","journal-title":"Sci Rep"},{"key":"6769_CR10","volume-title":"StatPearls [internet]","author":"RA Patterson","year":"2021","unstructured":"Patterson RA, Stankewicz HA. Penicillin, allergy. In:  StatPearls [internet]. Treasure Island: StatPearls Publishing; 2021 Jan."},{"key":"6769_CR11","first-page":"1189","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"WA Petri Jr","year":"2001","unstructured":"Petri WA Jr. Penicillins, cephalosporins, and other \u03b2-lactam antibiotics. In: Hardman JG, Limbird LE, editors. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Medical; 2001. p. 1189\u2013218.","edition":"10"},{"issue":"10","key":"6769_CR12","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S1473-3099(20)30857-4","volume":"21","author":"T Bettuzzi","year":"2021","unstructured":"Bettuzzi T, Jourdes A, Robineau O, et al. Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study. Lancet Infect Dis. 2021;21(10):1441\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(20)30857-4.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"6769_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/095646240401500511","volume":"30","author":"CM Marra","year":"2000","unstructured":"Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating cefriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2000;30(3):540\u20134. https:\/\/doi.org\/10.1177\/095646240401500511.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"6769_CR14","doi-asserted-by":"publisher","first-page":"CD011399","DOI":"10.1002\/14651858.CD011399.pub2","volume":"5","author":"D Buitrago-Garcia","year":"2019","unstructured":"Buitrago-Garcia D, Mart\u00ed-Carvajal AJ, Jimenez A, et al. Antibiotic therapy for adults with neurosyphilis. Cochrane Database Syst Rev. 2019;5(5):CD011399. https:\/\/doi.org\/10.1002\/14651858.CD011399.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"6769_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1258\/ijsa.2008.008279","volume":"19","author":"M Kingston","year":"2008","unstructured":"Kingston M, French P, Goh B, et al. UK national guidelines on the management of syphilis 2008. Inter J STD AIDS. 2008;19(11):729\u201340. https:\/\/doi.org\/10.1258\/ijsa.2008.008279.","journal-title":"Inter J STD AIDS"},{"issue":"3","key":"6769_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","volume":"35","author":"M Janier","year":"2021","unstructured":"Janier M, Unemo M, Dupin N, et al. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35(3):574\u201388. https:\/\/doi.org\/10.1111\/jdv.16946.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"6769_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000347109","volume":"226","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Lin LR, Liu GL, et al. Clinical spectrum of neurosyphilis among HIV-negative patients in the modern era. Dermatology. 2013;226(2):148\u201356. https:\/\/doi.org\/10.1159\/000347109.","journal-title":"Dermatology."},{"issue":"2","key":"6769_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/S1041610205002693","volume":"18","author":"KI Shulman","year":"2006","unstructured":"Shulman KI, Herrmann N, Brodaty H, et al. IPA survey of brief cognitive screening instruments. Int Psychogeriatr. 2006;18(2):281\u201394. https:\/\/doi.org\/10.1017\/S1041610205002693.","journal-title":"Int Psychogeriatr"},{"issue":"1-2","key":"6769_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000493866","volume":"80","author":"ML Tong","year":"2018","unstructured":"Tong ML, Chen YY, Zhu XZ, et al. Comparison of clinical and laboratory characteristics of general paresis and non-neurosyphilis dementia. Eur Neurol. 2018;80(1-2):82\u20136. https:\/\/doi.org\/10.1159\/000493866.","journal-title":"Eur Neurol"},{"issue":"5","key":"6769_CR20","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1111\/j.1755-5949.2010.00183.x","volume":"16","author":"KG Ghanem","year":"2010","unstructured":"Ghanem KG. Review: Neurosyphilis: a historical perspective and review. CNS Neurosci Ther. 2010;16(5):e157\u201368. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00183.x.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"6769_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13555-020-00361-3","volume":"10","author":"XJ Shang","year":"2020","unstructured":"Shang XJ, He CF, Tang B, et al. Neuroimaging features, follow-up analyses, and comparisons between asymptomatic and symptomatic neurosyphilis. Dermatol Ther (Heidelb). 2020;10(2):273\u201383. https:\/\/doi.org\/10.1007\/s13555-020-00361-3.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"6769_CR22","volume-title":"StatPearls [internet]","author":"A Dhakal","year":"2021","unstructured":"Dhakal A, Sbar E. Jarisch Herxheimer reaction. 2021 may 4. In:  StatPearls [internet]. Treasure Island: StatPearls Publishing; 2021."},{"key":"6769_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/1471-2334-13-605","volume":"13","author":"S Jinno","year":"2013","unstructured":"Jinno S, Anker B, Kaur P, et al. Predictors of serological failure afer treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect Dis. 2013;13:605. https:\/\/doi.org\/10.1186\/1471-2334-13-605.","journal-title":"BMC Infect Dis"},{"issue":"24","key":"6769_CR24","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.jacc.2015.10.036","volume":"66","author":"SJ Pocock","year":"2015","unstructured":"Pocock SJ, Clayton TC, Stone GW. Design of major randomized trials: part 3 of a 4-part series on statistics for clinical trials. J Am Coll Cardiol. 2015;66(24):2757\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2015.10.036.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"6769_CR25","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.13288\/j.11-2166\/r.2016.14.009","volume":"57","author":"K Zhang","year":"2016","unstructured":"Zhang K, Li WY, Fen S, et al. Statistical analyses and reporting specification of dropouts, withdrawals and loss to follow-ups of participants in clinical trials. J Tradit Chin Med. 2016;57(14):1204\u20137. https:\/\/doi.org\/10.13288\/j.11-2166\/r.2016.14.009.","journal-title":"J Tradit Chin Med"},{"issue":"6","key":"6769_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.110.015255","volume":"123","author":"EM Antman","year":"2011","unstructured":"Antman EM. Evidence and education. Circulation. 2011;123(6):681\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.015255.","journal-title":"Circulation"},{"issue":"1","key":"6769_CR27","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/s12879-019-4582-2","volume":"19","author":"Y Lu","year":"2019","unstructured":"Lu Y, Ke W, Yang L, et al. Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study. BMC Infect Dis. 2019;19(1):1017. https:\/\/doi.org\/10.1186\/s12879-019-4582-2.","journal-title":"BMC Infect Dis"},{"key":"6769_CR28","doi-asserted-by":"publisher","first-page":"2426313","DOI":"10.1155\/2019\/2426313","volume":"2019","author":"W Li","year":"2019","unstructured":"Li W, Jiang M, Xu D, et al. Clinical and laboratory characteristics of symptomatic and asymptomatic neurosyphilis in HIV-negative patients: a retrospective study of 264 cases. Biomed Res Int. 2019;2019:2426313. https:\/\/doi.org\/10.1155\/2019\/2426313.","journal-title":"Biomed Res Int"},{"issue":"7","key":"6769_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/591534","volume":"47","author":"CM Marra","year":"2008","unstructured":"Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis. 2008;47(7):893\u20139. https:\/\/doi.org\/10.1086\/591534.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6769_CR30","doi-asserted-by":"publisher","first-page":"9911","DOI":"10.1038\/s41598-017-10387-x","volume":"7","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Tong ML, Lin LR, et al. Serological response predicts normalization of cerebrospinal fluid abnormalities at six months after treatment in HIV-negative neurosyphilis patients. Sci Rep. 2017;7(1):9911. https:\/\/doi.org\/10.1038\/s41598-017-10387-x.","journal-title":"Sci Rep"},{"issue":"4","key":"6769_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.diagmicrobio.2013.01.013","volume":"75","author":"ML Tong","year":"2013","unstructured":"Tong ML, Liu LL, Zeng YL, et al. Laboratory findings in neurosyphilis patients with epileptic seizures alone as the initial presenting symptom. Diagn Microbiol Infect Dis. 2013;75(4):377\u201380. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.01.013.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"6769_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.23736\/S0026-4806.18.05694-X","volume":"109","author":"Z Li","year":"2018","unstructured":"Li Z, Lu Y, Hua Y, et al. Study on influence factors related to antibiotic treatment of neurosyphilis. Minerva Med. 2018;109(6):491\u20133. https:\/\/doi.org\/10.23736\/S0026-4806.18.05694-X.","journal-title":"Minerva Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06769-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T18:07:16Z","timestamp":1664647636000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06769-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6769"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06769-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol was reviewed and approved by the Medical Ethics Committee of the Chinese Academy of Medical Sciences Institute of Dermatology and the National Centre for STD Control in Nanjing (approval number: 2020-KY-022). If any modifications are made, amendments will be reviewed and approved by the ethics committee. Two copies of written informed consent should be signed from each patient before enrolment in the study; one copy will be for the participant and the other for the investigator.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"835"}}